[Clinical features of IgG4-related lung disease]

W Zhang1, M Q Zhang1, P H Gong1

  • 1Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing 100044, China.

Insights

This study reveals that IgG4-related lung disease often presents atypically, with many patients being asymptomatic. Clinical features and imaging outcomes do not significantly differ between symptomatic and asymptomatic individuals.

Area of Science:

  • Pulmonology
  • Immunology
  • Radiology

Background:

  • Immunoglobulin G4-related disease (IgG4-RD) is a multisystemic fibroinflammatory condition.
  • IgG4-related lung disease (IgG4-RLD) is an under-recognized manifestation of IgG4-RD.
  • Understanding the clinical spectrum of IgG4-RLD is crucial for timely diagnosis and management.

Purpose of the Study:

  • To elucidate the diverse clinical manifestations of IgG4-related lung disease.
  • To analyze laboratory findings, imaging characteristics, and prognostic factors in IgG4-RLD patients.
  • To compare clinical features and outcomes between patients with and without respiratory symptoms.

Main Methods:

  • Retrospective analysis of clinical data from 60 patients diagnosed with IgG4-RLD.
  • Inclusion criteria: Diagnosis of IgG4-RLD between February 2012 and May 2021.
  • Data collected: Clinical presentation, serological markers (IgG4, IgE, complement), imaging findings, pathology, and treatment outcomes.

Main Results:

  • Atypical presentations are common, with a high proportion of asymptomatic cases (63.3% nodular changes, 56.7% lymphadenopathy, 51.7% GGOs).
  • Elevated serum IgG4 (>1.35 g/L) was observed in 94.6% of patients. Other common findings included elevated IgE (79.2%) and decreased C3/C4 (53.7%).
  • Patients with respiratory symptoms showed higher total IgG and eosinophils, but no significant differences in IgG4, IgE, complement, or treatment outcomes compared to asymptomatic patients.

Conclusions:

  • IgG4-related lung disease exhibits heterogeneous clinical and imaging features, often presenting asymptomatically.
  • Multiple concurrent imaging abnormalities are frequent in IgG4-RLD.
  • The presence or absence of respiratory symptoms does not significantly alter the main clinical features or imaging outcomes of IgG4-RLD.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
381
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
127
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
206